ADMA Biologics furnishes January 2024 corporate presentation; no specific financial or operational updates disclosed

ADMA BIOLOGICS, INC.

Filing furnishes a corporate presentation under Item 7.01 Regulation FD.
Presentation titled 'Realizing the Potential of Specialty Biologics with Groundbreaking Immunotechnology'.
No earnings, guidance, or material business developments provided in the exhibit.
Presentation is available on ADMA's website under Investors section.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.